Christopher T. Skidmore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christopher T. Skidmore has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Michael R. Sperling
Farber Institute for Neuroscience, Department of Neurology, Thomas Jefferson University, Philadelphia, USA
4 shared publications - Ashwini Sharan
Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, Pennsylvania, USA
2 shared publications - Dawn Eliashiv
Neurology, David Geffen School of Medicine at University of California, Los Angeles
2 shared publications - Gaelle Eve Doucet
Institute for Human Neuroscience, Boys Town National Research Hospital, Omaha, NE, United States
2 shared publications - Joseph I. Tracy
Farber Institute for Neuroscience, Department of Neurology, Thomas Jefferson University, Philadelphia, USA
2 shared publications - Vikram R. Rao
Department of Neurology and Weill Institute for Neurosciences University of California, San Francisco San Francisco California USA
2 shared publications
Latest Publications
- Open Access
- 12 May 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106  (9) , e214875
Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy
Background and ObjectivesNeuromodulation therapies are approved for the treatment of focal epilepsy based on data from randomized controlled trials (RCTs). After approval of a responsive direct bra...
- 12 May 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106  (9) , e214875
Open AccessPostapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy
Background and ObjectivesNeuromodulation therapies are approved for the treatment of focal epilepsy based on data from randomized controlled trials (RCTs). After approval of a responsive direct bra...
- 1 February 2025
- Published by Wolters Kluwer Health in Continuum
- Vol. 31  (1) , 61-80
Neuroimaging in Epilepsy
OBJECTIVE: The goal of this article is to review the use of neuroimaging in the treatment of new-onset seizures and epilepsy. The article will focus predominantly on MRI because this is the most common modality, but it will also review others that are often used in individuals being considered for epilepsy surgery. The article also reviews common causes of epilepsy and their appearance on imaging and various imaging tools that can be combined to assist in the care of people with epilepsy. LATEST DEVELOPMENTS: MRI has revolutionized the ability to diagnose the cause of many forms of epilepsy. However, to maximize the diagnostic power of MRI, it is essential to order the correct imaging sequences. In this article, the harmonized neuroimaging of epilepsy structural sequences (HARNESS) MRI protocol proposed by the International League Against Epilepsy is discussed. ESSENTIAL POINTS: MRI is the preferred imaging modality to identify lesions associated with epilepsy. Protocols should include thin-cut, no-gap sequences to permit the identification of small epileptogenic lesions, and studies should be reviewed with an understanding of all the clinical information to help guide the identification of potential lesions.
- 1 February 2025
- Published by Wolters Kluwer Health in Continuum
- Vol. 31  (1) , 61-80
Neuroimaging in Epilepsy
OBJECTIVE: The goal of this article is to review the use of neuroimaging in the treatment of new-onset seizures and epilepsy. The article will focus predominantly on MRI because this is the most common modality, but it will also review others that are often used in individuals being considered for epilepsy surgery. The article also reviews common causes of epilepsy and their appearance on imaging and various imaging tools that can be combined to assist in the care of people with epilepsy. LATEST DEVELOPMENTS: MRI has revolutionized the ability to diagnose the cause of many forms of epilepsy. However, to maximize the diagnostic power of MRI, it is essential to order the correct imaging sequences. In this article, the harmonized neuroimaging of epilepsy structural sequences (HARNESS) MRI protocol proposed by the International League Against Epilepsy is discussed. ESSENTIAL POINTS: MRI is the preferred imaging modality to identify lesions associated with epilepsy. Protocols should include thin-cut, no-gap sequences to permit the identification of small epileptogenic lesions, and studies should be reviewed with an understanding of all the clinical information to help guide the identification of potential lesions.
- 1 December 2024
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 14  (6) , e200358
Long-Term Seizure Outcome With or Without Vagal Nerve Stimulation Therapy
To compare long-term seizure control in patients with long-term VNS (vagal nerve stimulator) stimulation (VNS-on) with those who discontinued VNS after >3 years (VNS-off). Patients with refractory epilepsy with VNS therapy for >3 years (and follow-up for >2 years after VNS discontinuation for VNS-off patients) were included. Patients with brain surgery p = 0.26; vs VNS-off at the last follow-up: 62.5%, p = 0.60). VNS-on patients had a significant reduction in seizure frequency at the last follow-up compared with baseline (median [Mdn] = -4.5 seizures/month, interquartile range [IQR] = 14.0, 56% reduction, p = 0.013). VNS-off patients also showed significant seizure reduction while still continuing VNS therapy (Mdn = -1.0 seizures/month, IQR = 13.0, 35% reduction, p = 0.020) and, after discontinuing therapy, at the last follow-up compared with baseline (Mdn = -3.2, IQR = 11.0, 52% reduction, p = 0.020). The 2 groups were comparable in seizure frequency change both at the last-on visit (absolute change, p = 0.62; relative change, p = 0.50) at the last follow-up (absolute change, p = 0.67; relative change, p = 0.76). Patients who discontinued VNS therapy and those who continued therapy had similar response during active treatment and similar long-term outcomes, suggesting that factors such as the natural disease course and/or medication treatment strongly affect long-term outcomes.
- 1 December 2024
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 14  (6) , e200358
Long-Term Seizure Outcome With or Without Vagal Nerve Stimulation Therapy
To compare long-term seizure control in patients with long-term VNS (vagal nerve stimulator) stimulation (VNS-on) with those who discontinued VNS after >3 years (VNS-off). Patients with refractory epilepsy with VNS therapy for >3 years (and follow-up for >2 years after VNS discontinuation for VNS-off patients) were included. Patients with brain surgery p = 0.26; vs VNS-off at the last follow-up: 62.5%, p = 0.60). VNS-on patients had a significant reduction in seizure frequency at the last follow-up compared with baseline (median [Mdn] = -4.5 seizures/month, interquartile range [IQR] = 14.0, 56% reduction, p = 0.013). VNS-off patients also showed significant seizure reduction while still continuing VNS therapy (Mdn = -1.0 seizures/month, IQR = 13.0, 35% reduction, p = 0.020) and, after discontinuing therapy, at the last follow-up compared with baseline (Mdn = -3.2, IQR = 11.0, 52% reduction, p = 0.020). The 2 groups were comparable in seizure frequency change both at the last-on visit (absolute change, p = 0.62; relative change, p = 0.50) at the last follow-up (absolute change, p = 0.67; relative change, p = 0.76). Patients who discontinued VNS therapy and those who continued therapy had similar response during active treatment and similar long-term outcomes, suggesting that factors such as the natural disease course and/or medication treatment strongly affect long-term outcomes.
- 1 January 2021
- Published by Elsevier in Epilepsy Research
- Vol. 169, 106532
Pregnancy outcomes of refractory epilepsy patients treated with Brain–responsive neurostimulation
- 1 January 2021
- Published by Elsevier in Epilepsy Research
- Vol. 169, 106532
Pregnancy outcomes of refractory epilepsy patients treated with Brain–responsive neurostimulation
- 6 April 2015
- Published by Wolters Kluwer Health in Neurology
- Vol. 84  (14_supplem)
Episodic Memory Deficits are related to Gray Matter Volume and Functional Connectivity Abnormalities in Temporal Lobe Epilepsy (S14.006)
- 6 April 2015
- Published by Wolters Kluwer Health in Neurology
- Vol. 84  (14_supplem)
Episodic Memory Deficits are related to Gray Matter Volume and Functional Connectivity Abnormalities in Temporal Lobe Epilepsy (S14.006)
- 26 March 2015
- Published by Cambridge University Press (CUP)
- p. 90-111
Subdural electrode implantation and recording in MRI-negative epilepsy surgery
- 26 March 2015
- Published by Cambridge University Press (CUP)
- p. 90-111
Subdural electrode implantation and recording in MRI-negative epilepsy surgery
- Open Access
- 10 March 2014
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 5, 23
Temporal Lobe Epilepsy and Surgery Selectively Alter the Dorsal, Not the Ventral, Default-Mode Network
The default-mode network (DMN) is a major resting-state network. It can be divided in 2 distinct networks: one is composed of dorsal and anterior regions (referred to as the dorsal DMN, dDMN), while the other involves the more posterior regions (referred to as the ventral DMN, vDMN). To date, no studies have investigated the potentially distinct impact of temporal lobe epilepsy (TLE) on these networks. In this context, we explored the effect of TLE and anterior temporal lobectomy (ATL) on the dDMN and vDMN. We utilized 2 resting-state fMRI sessions from left, right TLE patients (pre-/post-surgery) and normal controls (NCs, sessions 1/2). Using independent component analysis, we identified the 2 networks. We then evaluated for differences in spatial extent for each network between the groups, and across the scanning sessions. The results revealed that, pre-surgery, the dDMN showed larger differences between the three groups than the vDMN, and more particularly between right and left TLE than between the TLE patients and controls. In terms of change post-surgery, in both TLE groups, the dDMN also demonstrated larger changes than the vDMN. For the vDMN, the only changes involved the resected temporal lobe for each ATL group. For the dDMN, the left ATL group showed post-surgical increases in several regions outside the ictal temporal lobe. In contrast, the right ATL group displayed a large reduction in the frontal cortex. The results highlight that the 2 DMNs are not impacted by TLE and ATL in an equivalent fashion. Importantly, the dDMN was the more affected, with right ATL having a more deleterious effects on the dDMN than left ATL. We are the first to highlight that the dDMN more strongly bears the negative impact of TLE than the vDMN, suggesting there is an interaction between the side of pathology and DM subnetwork activity. Our findings have implications for understanding the impact TLE and subsequent ATL on the functions implemented by the distinct DMNs.
- 10 March 2014
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 5, 23
Open AccessTemporal Lobe Epilepsy and Surgery Selectively Alter the Dorsal, Not the Ventral, Default-Mode Network
The default-mode network (DMN) is a major resting-state network. It can be divided in 2 distinct networks: one is composed of dorsal and anterior regions (referred to as the dorsal DMN, dDMN), while the other involves the more posterior regions (referred to as the ventral DMN, vDMN). To date, no studies have investigated the potentially distinct impact of temporal lobe epilepsy (TLE) on these networks. In this context, we explored the effect of TLE and anterior temporal lobectomy (ATL) on the dDMN and vDMN. We utilized 2 resting-state fMRI sessions from left, right TLE patients (pre-/post-surgery) and normal controls (NCs, sessions 1/2). Using independent component analysis, we identified the 2 networks. We then evaluated for differences in spatial extent for each network between the groups, and across the scanning sessions. The results revealed that, pre-surgery, the dDMN showed larger differences between the three groups than the vDMN, and more particularly between right and left TLE than between the TLE patients and controls. In terms of change post-surgery, in both TLE groups, the dDMN also demonstrated larger changes than the vDMN. For the vDMN, the only changes involved the resected temporal lobe for each ATL group. For the dDMN, the left ATL group showed post-surgical increases in several regions outside the ictal temporal lobe. In contrast, the right ATL group displayed a large reduction in the frontal cortex. The results highlight that the 2 DMNs are not impacted by TLE and ATL in an equivalent fashion. Importantly, the dDMN was the more affected, with right ATL having a more deleterious effects on the dDMN than left ATL. We are the first to highlight that the dDMN more strongly bears the negative impact of TLE than the vDMN, suggesting there is an interaction between the side of pathology and DM subnetwork activity. Our findings have implications for understanding the impact TLE and subsequent ATL on the functions implemented by the distinct DMNs.
- 1 January 2010
- Published by Springer Nature
- p. 441-442
Focal Inhibitory Seizures
- 1 January 2010
- Published by Springer Nature
- p. 435-436
Focal Myoclonic Seizures